Table 4.
Gender-wise distribution of subjects
Sex | Group A (triamcinolone) | Group B (PRP) | ||
---|---|---|---|---|
N = 20 | N = 20 | |||
No. | % | No. | % | |
Female | 13 | 65.00 | 9 | 45.00 |
Male | 7 | 35.00 | 11 | 55.00 |
P value = 0.204 (Pearson chi-square test), χ2 = 1.616, df = 1
Gender-wise distribution of subjects
Sex | Group A (triamcinolone) | Group B (PRP) | ||
---|---|---|---|---|
N = 20 | N = 20 | |||
No. | % | No. | % | |
Female | 13 | 65.00 | 9 | 45.00 |
Male | 7 | 35.00 | 11 | 55.00 |
P value = 0.204 (Pearson chi-square test), χ2 = 1.616, df = 1